It was reported in previous studies that risk factors for AAA formation included higher disease activity, longer disease duration, concomitant infection, intramuscular route of administration, and specific human leukocyte antigen alleles such as HLA-DQA1*05 (12–17). The gene discussed is HLA-DQA1; the disease is infection.